LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Flow‐Mediated Dilatation as a Biomarker of AAA Progression: FT06.

Photo by nci from unsplash

an overall in-hospital mortality of 7.2% (7 of 97). Follow-up data were obtained from all patients, and the mean follow-up time was 43.36 25.5 months. The 5-year survival rate by… Click to show full abstract

an overall in-hospital mortality of 7.2% (7 of 97). Follow-up data were obtained from all patients, and the mean follow-up time was 43.36 25.5 months. The 5-year survival rate by Kaplan-Meier analysis was 86. 6%. Three patients with type I endoleak was successfully resolved during the operation. No endograft caudal migration occurred. Late aortic rupture was found in two patients, and two patients received reoperations during the follow-up period. No postoperative paraplegia was found. Conclusions: The long-term outcomes of hybrid total arch repair for dissecting aneurysms are satisfactory. This procedure may be an alternative for conventional total arch replacement for high-risk patients.

Keywords: mediated dilatation; biomarker aaa; aaa progression; dilatation biomarker; flow mediated; progression ft06

Journal Title: Journal of Vascular Surgery
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.